trial · primary record
Petosemtamab
Left-sided Colorectal Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 960 |
| Primary completion | 2031-09 |
| Primary endpoint | Progression-free Survival (PFS) per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 as Assessed by Blinded Independent Central Review (BICR) |
| Registry ID | NCT07702032 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:03.738Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07702032
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Petosemtamab · compound